| scholarly article | Q13442814 |
| P356 | DOI | 10.1056/NEJM196306132682401 |
| P698 | PubMed publication ID | 13936775 |
| P2093 | author name string | MERRILL JP | |
| HARRISON JH | |||
| DAMMIN GJ | |||
| WILSON RE | |||
| MURRAY JE | |||
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1315-1323 | |
| P577 | publication date | 1963-06-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | Prolonged survival of human-kidney homografts by immunosuppressive drug therapy. | |
| P478 | volume | 268 |
| Q43633114 | 1954. |
| Q53513591 | 20th-century advances in drug therapy in oncology--Part I. |
| Q42798512 | 5-Azacytidine specifically inhibits the NIH-3T3 PCD process induced by TNF-alpha and cycloheximide via affecting BCL-XL. |
| Q40200614 | 6-Mercaptopurine, an activator of Nur77, enhances transcriptional activity of HIF-1alpha resulting in new vessel formation |
| Q34629933 | 6-Thioguanine reactivates epigenetically silenced genes in acute lymphoblastic leukemia cells by facilitating proteasome-mediated degradation of DNMT1 |
| Q78392942 | A CASE OF DERMATOMYOSITIS TREATED WITH 6-MERCAPTOPURINE AND AZATHIOPRINE |
| Q33602527 | A comprehensive review of immunosuppression used for liver transplantation |
| Q39945546 | A decade followup in early cases of renal homotransplantation |
| Q42535946 | A modern Cosmas and Damian: Sir Roy Calne and Thomas Starzl receive the 2012 Lasker~Debakey Clinical Medical Research Award |
| Q76947646 | ANALYSIS OF MECHANISM OF IMMUNOSUPPRESSIVE DRUGS IN RENAL HOMOTRANSPLANTATION |
| Q33567138 | Acquired immunologic tolerance: with particular reference to transplantation |
| Q73932596 | Advances in the development of immunosuppressive agents in organ transplantation |
| Q48931607 | An old friendship revisited: plastic surgery and transplantation |
| Q35544018 | Anti-interleukin-2 receptor antibodies for the prevention of rejection in pediatric renal transplant patients: current status. |
| Q37691180 | Antibody immunosuppressive therapy in solid-organ transplant: Part I. |
| Q39897265 | Antineoplastic and immunosuppressive drugs. II. Therapeutic uses |
| Q39653364 | Azathioprine hypersensitivity presenting as septic shock with encephalopathy |
| Q40037472 | Azathioprine therapy of ?autoimmune? diseases |
| Q90705186 | Azathioprine-induced Agranulocytosis and Severe Alopecia After Kidney Transplantation Associated With a NUDT15 Polymorphism: A Case Report |
| Q71540789 | Azathioprine: an adjunct to surgical therapy of granulomatous enteritis |
| Q34190823 | Azathioprine: old drug, new actions |
| Q72648752 | Beneficial effects of conversion from cyclosporin to azathioprine after kidney transplantation |
| Q77093704 | CURRENT EVALUATION OF HUMAN KIDNEY TRANSPLANTATION |
| Q34241674 | Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance |
| Q39964262 | Chemical suppression of adaptive immunity |
| Q39016806 | Chemoprevention of colorectal cancer in inflammatory bowel disease |
| Q71171020 | Clinical effectiveness of 6-mercaptopurine in bronchial asthma |
| Q71522220 | Clinical immunologic responsiveness in malignant disease.I. Delayed hypersensitivity reaction and the effect of cytotoxic drugs |
| Q41338694 | Clinical investigators as critical determinants in pharmaceutical innovation |
| Q69938640 | Clinical patterns of renal allograft rejection |
| Q43793490 | Clinical use of immunosuppressive drugs: part II. |
| Q38573616 | Complement Interception Across Humoral Incompatibility in Solid Organ Transplantation: A Clinical Perspective |
| Q36909355 | Corticosteroid withdrawal in kidney transplantation: the present status |
| Q70804117 | Cosmas and Damian in the 20th Century? |
| Q47760880 | Cross-sex transplantation alters gene expression and enhances inflammatory response in the transplanted kidneys |
| Q38096463 | Current pharmacotherapeutical options for the prevention of kidney transplant rejection |
| Q39284584 | Current status of vascularized composite tissue allotransplantation |
| Q37464333 | Cyclophosphamide and human organ transplantation |
| Q35711226 | Cyclosporine in thoracic organ transplantation |
| Q46451323 | Decoding the Molecular Basis for the Population Mechanism of the Triplet Phototoxic Precursors in UVA Light-Activated Pyrimidine Anticancer Drugs. |
| Q35620073 | Dendritic cells: emerging pharmacological targets of immunosuppressive drugs |
| Q34320381 | Dr. Joseph E. Murray (1919-2012): a life of curiosity, humanism, and persistence |
| Q41815894 | EXTRACORPOREAL PERFUSION FOR OBTAINING POSTMORTEM HOMOGRAFTS |
| Q50643195 | Economic evaluation of end stage renal disease treatment. |
| Q69957955 | Effects of cortisol on the microvasculature of mouse skin isografts and allografts |
| Q71158223 | Erythremia after Renal Transplantation |
| Q35711203 | Evolution of immunosuppression in liver transplantation: contribution of cyclosporine |
| Q34275840 | Evolution of liver transplantation |
| Q37355472 | Evolving concepts in the selection of immunosuppression regimen for liver transplant recipients |
| Q43655192 | Ex vivo alloanergization with belatacept: a strategy to selectively modulate alloresponses after transplantation |
| Q38110753 | Exercise limitation following transplantation. |
| Q79819422 | Experience with cyclosporine |
| Q72311840 | Experimental Prevention of Nerve Homograft Rejection by Use of Immunosuppressive Drugs |
| Q34257321 | FACTORS IN SUCCESSFUL RENAL TRANSPLANTATION. |
| Q67678922 | FK506: the promise and the paradox |
| Q78247085 | FUNCTIONAL EVALUATION OF HUMAN KIDNEY TRANSPLANTS WITH RENOGRAMS |
| Q33993337 | Factors in the Development of Liver Transplantation. |
| Q40945505 | Five years' experience in renal transplantation with immunosuppressive drugs: survival, function, complications, and the role of lymphocyte depletion by thoracic duct fistula |
| Q53644256 | Forty years of microsurgery: What's next? |
| Q34248985 | France and the early history of organ transplantation |
| Q37060473 | Graft and patient survival in kidney transplant recipients selected for de novo steroid-free maintenance immunosuppression |
| Q36078907 | Hand transplantation. A future clinical option? |
| Q33930853 | Historic landmarks in clinical transplantation: conclusions from the consensus conference at the University of California, Los Angeles |
| Q36933185 | Historical overview of transplantation |
| Q24596303 | History of clinical transplantation |
| Q40033340 | Homo- and heterotransplantation |
| Q39969663 | Human tissue transplantation |
| Q42067805 | IMMUNOLOGIC STUDIES IN HUMAN ORGAN TRANSPLANTATION. I. OBSERVATION AND CHARACTERIZATION OF SUPPRESSED CUTANEOUS REACTIVITY IN UREMIA |
| Q37563822 | IMPROVING LONG-TERM OUTCOMES IN KIDNEY TRANSPLANTATION: TOWARDS A NEW PARADIGM OF POST-TRANSPLANT CARE IN THE UNITED STATES. |
| Q34684523 | INFECTIOUS DISEASES ASSOCIATED WITH RENAL HOMOTRANSPLANTATION |
| Q54712733 | INSULIN RESISTANCE; STUDY OF EFFECT OF 6-MERCAPTOPURINE |
| Q61797363 | ImmunoSPdb: an archive of immunosuppressive peptides |
| Q70004944 | Immunodiagnostic test for transplant rejection |
| Q34286455 | Immunosuppression and other nonsurgical factors in the improved results of liver transplantation |
| Q34484801 | Immunosuppressive Medications |
| Q33908046 | Immunosuppressive drugs: the first 50 years and a glance forward |
| Q74597203 | Immunosuppressive therapy |
| Q41450556 | Infectious pulmonary disease in patients receiving immunosuppressive therapy for organ transplantation |
| Q37688995 | Interconnections between apoptotic and autophagic pathways during thiopurine-induced toxicity in cancer cells: the role of reactive oxygen species |
| Q64097878 | Joseph Murray (1919-2012): First transplant surgeon |
| Q39118325 | Kidney Transplantation With Ultralong-Term (42 Years) Survival of a 100-Year-Old Graft. |
| Q71207094 | Kidney transplantation in man: analysis of eleven cases |
| Q34070112 | LC-MS/MS coupled with stable isotope dilution method for the quantification of 6-thioguanine and S(6)-methylthioguanine in genomic DNA of human cancer cells treated with 6-thioguanine |
| Q34294947 | Lessons of organ-induced tolerance learned from historical clinical experience |
| Q34275290 | Liver transplantation in the ciclosporin era. |
| Q74615969 | Living related and cadaveric kidney transplantation--what are the major differences? |
| Q39824383 | Long-Term Renal Allograft Survival in the United States: A Critical Reappraisal |
| Q34289310 | Long-term (25-year) survival after renal homotransplantation--the world experience |
| Q45139797 | Long-term survival after renal transplantation in humans: (with special reference to histocompatibility matching, thymectomy, homograft glomerulonephritis, heterologous ALG , AND RECIPIENT MALIGNANCY). |
| Q76976288 | MORPHOLOGICAL OBSERVATIONS IN HUMAN KIDNEY TRANSPLANTATION |
| Q36085841 | Mechanisms of action of mycophenolate mofetil |
| Q46502944 | Medical and ethical considerations in uterus transplantation |
| Q40482744 | Microsurgical research—a personal experience |
| Q24298694 | Molecular cloning and characterization of a novel muscle adenylosuccinate synthetase, AdSSL1, from human bone marrow stromal cells |
| Q37955182 | Multiple forms of DNA damage caused by UVA photoactivation of DNA 6-thioguanine |
| Q55547403 | New frontiers in immunosuppression. |
| Q40785466 | New immunosuppressive agents for pediatric transplantation |
| Q48406876 | Nobel lecture in physiology or medicine--1988. The purine path to chemotherapy |
| Q38949407 | Notch Signaling and Alloreactivity. |
| Q58801877 | Nuclear Receptor Nur77 Deficiency Alters Dendritic Cell Function |
| Q55217786 | OBLITERATIVE VASCULAR CHANGES IN FOUR HUMAN KIDNEY HOMOTRANSPLANTS. |
| Q34286210 | Organ transplantation--then and now |
| Q42864023 | Organ transplantation: a practical triumph and epistemologic collapse |
| Q78441551 | PATHOLOGICAL CHANGES IN 37 HUMAN RENAL HOMOTRANSPLANTS TREATED WITH IMMUNOSUPPRESSIVE DRUGS |
| Q34701213 | Pancreas and islet cell transplantation |
| Q68177096 | Pediatric liver transplantation |
| Q34965144 | Personal Reflections in Transplantation |
| Q24644696 | Peter Brian Medawar: father of transplantation |
| Q93513583 | Pharmacokinetics of 6-thiouric acid and 6-mercaptopurine in renal allograft recipients after oral administration of azathioprine |
| Q40450258 | Pharmacologic Treatment of Noninfectious Uveitis. |
| Q72304467 | Primary care of the renal transplant patient |
| Q38015284 | Principles of immunosuppression. |
| Q35893641 | Prope tolerance--the future of organ transplantation from the laboratory to the clinic |
| Q36752004 | Prospective randomized trial of maintenance immunosuppression with rapid discontinuation of prednisone in adult kidney transplantation. |
| Q76894598 | REJECTION PROCESSES IN HUMAN HOMOTRANSPLANTED KIDNEYS |
| Q76947634 | RENAL HETEROTRANSPLANTATION IN MAN |
| Q34296206 | RENAL HOMOTRANSPLANTATION; LATE FUNCTION AND COMPLICATIONS |
| Q76506361 | RENAL TRANSPLANTATION IN MAN: A REPORT OF FIVE CASES, USING CADAVERIC DONORS |
| Q37731525 | Rabbit antithymocyte globulin (thymoglobulin): 25 years and new frontiers in solid organ transplantation and haematology |
| Q33681499 | Recent advances in immunosuppressants. |
| Q28080994 | Reconsidering the detection of tolerance to individualize immunosuppression minimization and to improve long-term kidney graft outcomes |
| Q73931682 | Renal cellular transport, metabolism, and cytotoxicity of S-(6-purinyl)glutathione, a prodrug of 6-mercaptopurine, and analogues |
| Q72753037 | Renal transplantation |
| Q70256893 | Renal transplantation in children |
| Q67496103 | Renal transplantation: a twenty-five year experience |
| Q77632121 | Results of various immunosuppressive regimens at our transplantation center |
| Q36619363 | Review of the early diagnoses and assessment of rejection in vascularized composite allotransplantation |
| Q77093710 | STUDIES OF RENAL HOMOTRANSPLANTATION IN MAN |
| Q76894601 | STUDY OF RENAL VESSELS BY MICRODISSECTION IN HUMAN TRANSPLANTATION |
| Q43614533 | Selection of patients for kidney organ transplantation |
| Q71190061 | Skin homograft survival in cancer chemotherapy patients |
| Q53536679 | Some landmarks in the evolution of transplantation. |
| Q92635429 | Stem Cell Therapies in Kidney Diseases: Progress and Challenges |
| Q34497811 | Steps in immunosuppression for renal transplantation |
| Q37318299 | Steroid-free maintenance immunosuppression in kidney transplantation: is it time to consider it as a standard therapy? |
| Q37220860 | Steroids and Biologic Agents in the Intensive Care Unit |
| Q84948304 | Surface Properties of Cancer Cells |
| Q42371474 | Surgery: art or science? Birth of organ transplantation |
| Q39749043 | Sympathetic ophthalmitis treated with azathioprine |
| Q38120321 | Systemic use of non-biologics in orofacial diseases: 2. Purine synthesis inhibitors |
| Q77093718 | THE COURSE OF RENAL HYPERTENSION AFTER BILATERAL NEPHRECTOMY AND TRANSPLANTATION |
| Q40980879 | THE REVERSAL OF REJECTION IN HUMAN RENAL HOMOGRAFTS WITH SUBSEQUENT DEVELOPMENT OF HOMOGRAFT TOLERANCE |
| Q34812058 | THE TREATMENT OF COCCIDIOIDAL MENINGITIS. THE USE OF AMPHOTERICIN B IN A GROUP OF 25 PATIENTS |
| Q76735129 | TREATMENT OF ACTIVE CHRONIC HEPATITIS AND LUPOID HEPATITIS WITH 6-MERCAPTOPURINE AND AZOTHIOPRINE |
| Q34340969 | Tacrolimus (FK506) and the pharmaceutical/academic/regulatory gauntlet |
| Q30278052 | Tacrolimus for the prevention and treatment of rejection of solid organ transplants |
| Q44812466 | Ten years of cyclosporine use in renal transplantation: a single-center experience with 479 renal transplants |
| Q35914820 | The Envy of Scholars: Applying the Lessons of the Framingham Heart Study to the Prevention of Chronic Kidney Disease |
| Q40782702 | The Familial Living Donor in Renal Transplantation |
| Q34920118 | The French Heritage in Clinical Kidney Transplantation |
| Q38442767 | The Immunomodulatory and Therapeutic Effects of Mesenchymal Stromal Cells for Acute Lung Injury and Sepsis |
| Q37181790 | The Pittsburgh randomized trial of tacrolimus compared to cyclosporine for hepatic transplantation |
| Q40035259 | The Present Status of Clinical Renal Homotransplantation |
| Q36253406 | The Role of Organ Transplantation in Pediatrics |
| Q34546381 | The argument for the use of mizoribine in renal transplantation: a meta-analysis and systemic review |
| Q42363995 | The ascension of clinical organ transplantation |
| Q34340940 | The birth of clinical organ transplantation |
| Q34265967 | The clinical pharmacology of 6-mercaptopurine |
| Q42147381 | The co-development of liver and kidney transplantation (1955-1967) |
| Q86725573 | The corneal transplant score: a simple corneal graft candidate calculator |
| Q34330449 | The current status of hepatic transplantation at the University of Pittsburgh |
| Q34330601 | The development of clinical renal transplantation |
| Q41293926 | The early days of transplantation |
| Q46705752 | The haemotoxicity of azathioprine in repeat dose studies in the female CD-1 mouse |
| Q37425987 | The history of human composite tissue allotransplantation |
| Q34330774 | The mystique of organ transplantation |
| Q41235055 | The origin of clinical organ transplantation revisited |
| Q39915023 | The pathophysiology of renal allograft rejection: A collective review |
| Q41450639 | The saga of liver replacement, with particular reference to the reciprocal influence of liver and kidney transplantation (1955-1967) |
| Q71176923 | The story of kidney transplantation |
| Q33735648 | The succession from kidney to liver transplantation. |
| Q39691682 | The therapeutic use of azathioprine in renal transplantation |
| Q36305435 | The thiopurines: an update |
| Q30352760 | The unfinished legacy of liver transplantation: emphasis on immunology. |
| Q41103969 | Thoracic Duct Fistula and Renal Transplantation |
| Q35585753 | Tissue engineering and regenerative medicine |
| Q35549320 | Transplant immunology |
| Q38114067 | Transplant tolerance: new insights and strategies for long-term allograft acceptance |
| Q34334037 | Transplantation milestones. Viewed with one- and two-way paradigms of tolerance |
| Q34572212 | Transplantation tolerance from a historical perspective |
| Q33534180 | Transplantation tolerance, microchimerism, and the two-way paradigm |
| Q39900432 | Transplantation: current developments and future directions |
| Q41275725 | Transplantation: the realization of a dream |
| Q39327904 | Ushering in the era of penile transplantation |
| Q37852766 | Uterine transplantation: a promising surrogate to surrogacy? |
| Q34414935 | Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from Lewis to brown Norway rats |
| Q52390670 | [Surgeons as recipients of the Nobel Prize for Medicine. Their life and work in the course of time]. |
Search more.